En préparation
IMOVA
A Study to Evaluate the Immunogenicity, Safety, and Tolerability of the Ervebo Vaccine Administered with Inmazeb in Healthy Adult Volunteers
Project Details
Principal Investigator
ARC: Aurélie C IT: Serge D STAT: Sylvain J
Duration
12 months
Sponsor
ANRS-MIE > Outside the Call for Proposals
Study start
01 Oct 2024
Objectives
Main Objectives
A Study to Evaluate the Immunogenicity, Safety, and Tolerability of the Ervebo Vaccine Administered with Inmazeb in Healthy Adult Volunteers
Secondary Objectives
A Phase IIa exploratory, randomized, open-label, 6-arm, single-center, parallel-group study
Research Team
The research team has not yet been filled in for this project.
Collaborate with us
We are open to partnerships with international research institutions and doctoral students.
Research Request
Estimated response time: 3-5 business days.
Keywords
CLINICAL RESEARCH
OUR PROJECTS
